Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407372
Max Phase: Preclinical
Molecular Formula: C31H43N3O6
Molecular Weight: 553.70
Molecule Type: Protein
Associated Items:
ID: ALA2407372
Max Phase: Preclinical
Molecular Formula: C31H43N3O6
Molecular Weight: 553.70
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C)[C@@H](Oc1ccc(C=O)cc1)c1ccccc1)C(=O)OC
Standard InChI: InChI=1S/C31H43N3O6/c1-8-21(4)26(31(38)39-7)32-30(37)27(33-29(36)25(34(5)6)18-20(2)3)28(23-12-10-9-11-13-23)40-24-16-14-22(19-35)15-17-24/h9-17,19-21,25-28H,8,18H2,1-7H3,(H,32,37)(H,33,36)/t21-,25-,26-,27-,28-/m0/s1
Standard InChI Key: JOGGKKOBPIHZTF-OZDPOCAXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 553.70 | Molecular Weight (Monoisotopic): 553.3152 | AlogP: 3.78 | #Rotatable Bonds: 15 |
Polar Surface Area: 114.04 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.83 | CX Basic pKa: 7.80 | CX LogP: 4.68 | CX LogD: 4.13 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.25 | Np Likeness Score: 0.38 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):